Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,496,612
-$95,081 QoQ
Shares Held
60,684
+2.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#647
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names. BMY ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,496,612 | 60,684 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,591,693 | 59,220 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,127,495 | 57,981 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,652,736 | 58,819 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,753,051 | 59,474 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,646,958 | 59,796 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $384,721 | 6,802 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $321,874 | 6,221 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $489,638 | 11,790 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $781,128 | 14,404 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,936,234 | 37,736 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,013,407 | 34,690 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,147,696 | 33,584 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,239,059 | 32,305 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,062,158 | 28,661 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,866,894 | 26,261 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,061,521 | 26,773 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,067,187 | 28,306 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,867,382 | 29,950 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,744,331 | 29,480 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,842,828 | 27,579 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,464,299 | 23,195 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,072,001 | 17,282 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $988,574 | 16,397 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $227,908 | 3,876 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $191,578 | 3,437 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||